Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke

Experimental Neurology

Volumn 217, Issue 2, 2009, Pages 328-335

  Sevimli, Sevgi ^a   Diederich, Kai ^a   Strecker, Jan Kolja ^a   Schilling, Matthias ^a   Klocke, Rainer ^a   Nikol, Sigrid ^a   Kirsch, Friederike ^b   Schneider, Armin ^b   Schäbitz, Wolf Rüdiger ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Sygnis Pharma AG   (Germany)

Author keywords

G CSF; Ischemic brain injury; MMP 9; Stroke recovery

Indexed keywords

GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GENE REPRESSION; GRANULOCYTE COLONY STIMULATING FACTOR DEFICIENCY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LASER CAPTURE MICRODISSECTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SENSORIMOTOR FUNCTION; SUBSTITUTION THERAPY; WILD TYPE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE; UP-REGULATION;

EID: 67349147860     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.03.018     Document Type: Article

References (44)

1. Asahi M., Asahi K., Jung J.C., del Zoppo G.J., Fini M.E., and Lo E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20 (2000) 1681-1689
2. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
3. Begley C.G., Lopez A.F., Nicola N.A., Warren D.J., Vadas M.A., Sanderson C.J., and Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 68 (1986) 162-166
4. Beray-Berthat V., Palmier B., Plotkine M., and Margaill I. Neutrophils do not contribute to infarction, oxidative stress, and NO synthase activity in severe brain ischemia. Exp. Neurol. 182 (2003) 446-454
5. del Zoppo G.J. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc. Brain Metab. Rev. 6 (1994) 47-96
6. del Zoppo G.J., and Mabuchi T. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 879-894
7. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J.C., Kawase M., Massengale J., and Chan P.H. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19 (1999) 1020-1028
8. Gibson C.L., Bath P.M., and Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25 (2005) 431-439
9. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., and Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 64 (2005) 763-769
10. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., and Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol, Heart Circ. Physiol. 289 (2005) H558-H568
11. Gorgen I., Hartung T., Leist M., Niehorster M., Tiegs G., Uhlig S., Weitzel F., and Wendel A. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J. Immunol. 149 (1992) 918-924
12. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., and Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25 (2005) 6401-6408
13. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat. Med. 8 (2002) 1363-1368
14. Hamann G.F., Okada Y., Fitridge R., and del Zoppo G.J. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26 (1995) 2120-2126
15. Hata R., Mies G., Wiessner C., Fritze K., Hesselbarth D., Brinker G., and Hossmann K.A. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J. Cereb. Blood Flow Metab. 18 (1998) 367-375
16. Heuschmann P.U., Kolominsky-Rabas P.L., Roether J., Misselwitz B., Lowitzsch K., Heidrich J., Hermanek P., Leffmann C., Sitzer M., Biegler M., Buecker-Nott H.J., and Berger K. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. Jama 292 (2004) 1831-1838
17. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., Kim Y.J., Soo Lee D., Sohn D.W., Han K.S., Oh B.H., Lee M.M., and Park Y.B. Effects of intracoronary infusion of peripheral blood stem-cell mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
18. Kawada H., Takizawa S., Takanashi T., Morita Y., Fujita J., Fukuda K., Takagi S., Okano H., Ando K., and Hotta T. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113 (2006) 701-710
19. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J. Cereb. Blood Flow Metab. 26 (2006) 402-413
20. Lee S.T., Chu K., Jung K.H., Ko S.Y., Kim E.H., Sinn D.I., Lee Y.S., Lo E.H., Kim M., and Roh J.K. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058 (2005) 120-128
21. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K.J., Basu S., Zhan Y.F., and Dunn A.R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84 (1994) 1737-1746
22. Lo E.H., Wang X., and Cuzner M.L. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J. Neurosci. Res. 69 (2002) 1-9
23. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4 (2003) 399-415
24. Lu C.Z., and Xiao B.G. G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia. Biochem. Soc. Trans. 34 (2006) 1327-1333
25. Lundblad R., Nesland J.M., and Giercksky K.E. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit. Care Med. 24 (1996) 820-826
26. Metcalf D. The colony stimulating factors. Discovery, development, and clinical applications. Cancer 65 (1990) 2185-2195
27. Minnerup J., Heidrich J., Wellmann J., Rogalewski A., Schneider A., and Schabitz W.R. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke (2008)
28. Mun-Bryce S., and Rosenberg G.A. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18 (1998) 1163-1172
29. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
30. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893 (2001) 104-112
31. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., Sommer C., and Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34 (2003) 745-751
32. Schabitz W.R., and Schneider A. New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol. Sci. 28 (2007) 157-161
33. Schabitz W.R., Laage R., Schwab S., Schneider D., Hamann G., Rosenkranz M., Veltkamp R., Fisher M., Grotta J., Hacke W., and Schneider A. AX200 (G-CSF) for the Treatment of Acute Ischemic Stroke (AXIS) (2008), Abstract Int. Stroke Conference, New Orleans Feb 20-22nd 2008
34. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., and Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115 (2005) 2083-2098
35. Six I., Gasan G., Mura E., and Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 458 (2003) 327-328
36. Solaroglu I., Cahill J., Jadhav V., and Zhang J.H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37 (2006) 1123-1128
37. Sprigg N., Bath P.M., Zhao L., Willmot M.R., Gray L.J., Walker M.F., Dennis M.S., and Russell N. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 37 (2006) 2979-2983
38. Unemori E.N., Bouhana K.S., and Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J. Biol. Chem. 265 (1990) 445-451
39. Valgimigli M., Rigolin G.M., Cittanti C., Malagutti P., Curello S., Percoco G., Bugli A.M., Della Porta M., Bragotti L.Z., Ansani L., Mauro E., Lanfranchi A., Giganti M., Feggi L., Castoldi G., and Ferrari R. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur. Heart J. 26 (2005) 1838-1845
40. van Gijn J., and Dennis M.S. Issues and answers in stroke care. Lancet 352 Suppl. 3 (1998) SIII23-SIII27
41. von Aulock S., Diterich I., Hareng L., and Hartung T. G-CSF: boosting endogenous production-a new strategy?. Curr. Opin. Investig. Drugs 5 (2004) 1148-1152
42. Weaver C.H., Buckner C.D., Longin K., Appelbaum F.R., Rowley S., Lilleby K., Miser J., Storb R., Hansen J.A., and Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82 (1993) 1981-1984
43. Welte K., Platzer E., Lu L., Gabrilove J.L., Levi E., Mertelsmann R., and Moore M.A. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 1526-1530
44. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., Meisetschlager G., von Wedel J., Bollwein H., Seyfarth M., Dirschinger J., Schmitt C., Schwaiger M., Kastrati A., and Schomig A. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. Jama 295 (2006) 1003-1010